Biotechnology, a strategic planning orphan: towards an effective strategy framework for biotechnology firms

PL Molloy, LW Johnson - Journal of Commercial …, 2016 - search.proquest.com
Drug development biotechnology firms are most appropriately conceptualized as
intermediaries in the pharmaceutical R&D value chain. Because they generally do not …
被引用次数：8 相关文章

Biotechnology, a strategic planning orphan: towards an effective strategy framework for biotechnology firms

PL Molloy, LW Johnson - Journal of Commercial Biotechnology, 2016 - go.gale.com
Drug development biotechnology firms are most appropriately conceptualized as
intermediaries in the pharmaceutical R&D value chain. Because they generally do not …

Biotechnology, a Strategic Planning Orphan: Towards an Effective Strategy Framework for Biotechnology Firms.

PL Molloy, LW Johnson - Journal of Commercial …, 2016 - search.ebscohost.com
Drug development biotechnology firms are most appropriately conceptualized as
intermediaries in the pharmaceutical R& D value chain. Because they generally do not …

Biotechnology, a strategic planning orphan: towards an effective strategy framework for biotechnology firms

PL Molloy, LW Johnson - Journal of …, 2016 - commercialbiotechnology.com
Drug development biotechnology firms are most appropriately conceptualized as
intermediaries in the pharmaceutical R&D value chain. Because they generally do not …

Biotechnology, a strategic planning orphan: towards an effective strategy framework for biotechnology firms

PL Molloy, LW Johnson - Journal of …, 2016 - researchbank.swinburne.edu.au
Drug development biotechnology frms are most appropriately conceptualized as
intermediaries in the pharmaceutical R&D value chain. Because they generally do not …